Burkert Pieske

1.1k total papers · 100.9k total citations
594 papers, 31.2k citations indexed

About

Burkert Pieske is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Burkert Pieske has authored 594 papers receiving a total of 31.2k indexed citations (citations by other indexed papers that have themselves been cited), including 472 papers in Cardiology and Cardiovascular Medicine, 111 papers in Molecular Biology and 74 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Burkert Pieske's work include Cardiovascular Function and Risk Factors (219 papers), Heart Failure Treatment and Management (143 papers) and Cardiac electrophysiology and arrhythmias (125 papers). Burkert Pieske is often cited by papers focused on Cardiovascular Function and Risk Factors (219 papers), Heart Failure Treatment and Management (143 papers) and Cardiac electrophysiology and arrhythmias (125 papers). Burkert Pieske collaborates with scholars based in Germany, United States and Austria. Burkert Pieske's co-authors include Gerd Hasenfuß, Lars S. Maier, Adriaan A. Voors, Carsten Tschöpe, Scott D. Solomon, Frank Edelmann, Elisabeth Kraigher‐Krainer, John J.V. McMurray, H. Just and Rolf Wachter and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Burkert Pieske

572 papers receiving 30.5k citations

Hit Papers

2014 ESC Guidelines on di... 1994 2026 2004 2015 2014 2007 2012 2020 2010 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
    2014 2.9k citations Perry Elliott, Aris Anastasakis et al. European Heart Journal profile →
  2. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
    2007 1.9k citations Walter J. Paulus, Carsten Tschöpe et al. European Heart Journal profile →
  3. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
    2012 878 citations Scott D. Solomon, Michael R. Zile et al. The Lancet profile →
  4. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
    2020 767 citations Paul W. Armstrong, Burkert Pieske et al. New England Journal of Medicine profile →
  5. Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
    2010 644 citations Karen Sliwa, Denise Hilfiker‐Kleiner et al. European Journal of Heart Failure profile →
  6. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium.
    1994 607 citations Gerd Hasenfuß, Hans Reinecke et al. Circulation Research profile →
  7. Mitochondrial function as a therapeutic target in heart failure
    2016 557 citations David A. Brown, Justin B. Perry et al. Nature Reviews Cardiology profile →
  8. Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
    2013 520 citations Frank Edelmann, Rolf Wachter et al. JAMA profile →
  9. Impaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction
    2013 520 citations Elisabeth Kraigher‐Krainer, Amil M. Shah et al. Journal of the American College of Cardiology profile →
  10. Altered microRNA expression in human heart disease
    2007 517 citations Sadakatsu Ikeda, Sek Won Kong et al. profile →
  11. Exercise Training in Heart Failure: From Theory to Practice. A Consensus Document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation
    2011 480 citations Massimo Piepoli, Viviane M. Conraads et al. European Journal of Heart Failure profile →
  12. Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction
    2011 449 citations Frank Edelmann, Götz Gelbrich et al. Journal of the American College of Cardiology profile →
  13. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction
    2015 277 citations Mihai Gheorghiade, Stephen J. Greene et al. JAMA profile →
  14. Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction
    2020 180 citations Paul W. Armstrong, Carolyn S.P. Lam et al. JAMA profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Burkert Pieske 24.3k 7.4k 3.8k 3.0k 2.4k 594 31.2k
Roberto Ferrari 20.0k 0.8× 5.6k 0.8× 5.5k 1.4× 3.5k 1.2× 2.2k 0.9× 769 31.3k
Michael R. Bristow 31.1k 1.3× 11.3k 1.5× 4.8k 1.3× 2.2k 0.7× 2.3k 0.9× 403 40.5k
Gerd Hasenfuß 23.3k 1.0× 9.8k 1.3× 4.9k 1.3× 4.1k 1.4× 2.4k 1.0× 606 32.4k
Michael R. Zile 32.9k 1.4× 4.5k 0.6× 5.0k 1.3× 3.8k 1.3× 4.5k 1.8× 574 39.3k
David M. Kaye 15.3k 0.6× 4.6k 0.6× 4.0k 1.0× 2.0k 0.7× 2.5k 1.0× 617 26.5k
John C. Burnett 22.9k 0.9× 6.1k 0.8× 3.7k 1.0× 2.3k 0.8× 5.5k 2.3× 577 32.0k
Arthur M. Feldman 22.0k 0.9× 6.8k 0.9× 4.4k 1.2× 1.6k 0.5× 1.8k 0.8× 333 29.7k
Wilson S. Colucci 21.7k 0.9× 9.5k 1.3× 4.3k 1.1× 1.3k 0.4× 3.1k 1.3× 318 32.8k
Hiroyuki Tsutsui 11.6k 0.5× 7.1k 1.0× 2.8k 0.7× 1.4k 0.5× 2.1k 0.8× 643 22.3k
Carolyn S.P. Lam 22.0k 0.9× 3.0k 0.4× 3.6k 0.9× 2.4k 0.8× 4.5k 1.8× 563 29.5k

Countries citing papers authored by Burkert Pieske

Since Specialization
Citations

This map shows the geographic impact of Burkert Pieske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burkert Pieske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burkert Pieske more than expected).

Fields of papers citing papers by Burkert Pieske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burkert Pieske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burkert Pieske. The network helps show where Burkert Pieske may publish in the future.

Co-authorship network of co-authors of Burkert Pieske

This figure shows the co-authorship network connecting the top 25 collaborators of Burkert Pieske. A scholar is included among the top collaborators of Burkert Pieske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burkert Pieske. Burkert Pieske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Ding Breakdown of academic impact, for papers by Charles E. Wade Breakdown of academic impact, for papers by Xin Wang Breakdown of academic impact, for papers by Yongfeng Hu Breakdown of academic impact, for papers by Roeland J. M. Nolte Breakdown of academic impact, for papers by James G. Fox Breakdown of academic impact, for papers by William C. de Groat Breakdown of academic impact, for papers by Tingjun Hou
Rankless by CCL
2026